Today: 10 June 2026
Bitcoin price snaps back above $70,000 after plunge, but options traders stay on guard
6 February 2026
1 min read

Bitcoin price snaps back above $70,000 after plunge, but options traders stay on guard

New York, February 6, 2026, 17:03 (EST) — After-hours trading.

Bitcoin bounced back Friday, jumping 11% to $70,304 after briefly sliding as low as $60,300 earlier in the session.

Late-week risk appetite steadied, giving U.S. stocks a strong push higher—chipmakers were out front. The Dow closed above 50,000 for the first time ever. S&P 500 gained close to 2%. The Nasdaq climbed over 2% as well, a move that took some heat off the speculative end of the market.

But the action felt less like a fresh break and more like markets catching their breath. Shaun Osborne, Scotiabank’s chief currency strategist, described it as “a day of consolidation” for risk assets. Gold popped roughly 4%, silver surged over 8%—both snapping back after wild swings. In crypto options, traders zeroed in on puts—bets on a drop—with Derive.xyz flagging concentrated interest at $60,000 to $50,000 strikes for Feb. 27 contracts. Reuters

Ether climbed too, rising around 11% to $2,052 after dipping to nearly $1,757 earlier in the session.

Still, the volatility hasn’t let up, and crypto prices are stuck well below their highs from early October. On Thursday, bitcoin tumbled alongside a wider selloff, with CoinGlass data putting bitcoin liquidations around $1 billion in just 24 hours. Some market watchers pointed to concerns that President Donald Trump’s choice for Fed chair, Kevin Warsh, might tighten policy by reducing the Fed’s balance sheet, pulling out liquidity. “The market fears a hawk with him,” said Julius Baer’s Manuel Villegas Franceschi. Mohit Kumar at Jefferies flagged a potential “vicious cycle” if plunging prices force miners and other leveraged holders to sell even more. Reuters

Strategy, the corporate bitcoin proxy run by Michael Saylor, reported a steeper loss for the quarter and disclosed it held 713,502 bitcoins as of Feb. 1, following a rocky period for digital assets. Saylor told investors that “the actions by big finance” and regulators remain “the fundamentals,” doubling down on his belief that long-term institutional adoption will outweigh swings in price. Reuters

The downturn hasn’t spared the smaller “digital asset treasury” outfits either—those that load up on crypto as part of their core business. Shares in the UK’s Smarter Web Company tumbled almost 18% Thursday, Reuters said, with other publicly traded bitcoin holders like Nakamoto Inc and Japan’s Metaplanet taking hits too, as the wave of selling spilled over from tokens to company stocks. Reuters

Focus shifts to bitcoin’s ability to hold the $70,000 line, with attention on how traders position themselves ahead of the Feb. 27 contract cycle—a pivotal moment for bitcoin derivatives.

Stock Market Today

  • Palantir Technologies (PLTR) Shares Seen Fairly Valued Amid Recent Decline
    June 10, 2026, 5:48 PM EDT. Palantir Technologies has seen its share price fall 13.2% over the past week and 21.3% year to date, following extraordinary gains in prior years. At $132.07 per share, Palantir trades slightly below its estimated intrinsic value of $145.11 based on a Discounted Cash Flow (DCF) analysis, suggesting a modest 9% discount. The company posted $2.69 billion in free cash flow over the past twelve months, with projections rising to $16.11 billion by 2030. Despite recent volatility tied to sentiment on artificial intelligence and software spending, Palantir remains fairly valued but not a clear bargain. Investors should monitor further market developments and valuation metrics to gauge future opportunities or risks.

Latest articles

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

10 June 2026
Parabilis Medicines soared 58% above its $20 IPO price to close at $31.60 in its Nasdaq debut after raising a record $670 million, reflecting strong investor demand for its Helicon drug platform ahead of a pivotal Phase 3 desmoid tumor trial planned for 2027; Regeneron’s $75 million private placement added credibility.
Joby Aviation Shares Slip After CFO Files to Sell Stock

Joby Aviation Shares Slip After CFO Files to Sell Stock

10 June 2026
Joby Aviation fell 4.47% to $8.86 after CFO Rodrigo Brumana disclosed selling 78,489 shares under a prearranged 10b5-1 plan, with no new certification or commercial-launch updates, leaving investors focused on regulatory progress and cash burn as the key catalysts for the stock.
YY Group Shares Spike as Humanoid Robot Plans Unveiled

YY Group Shares Spike as Humanoid Robot Plans Unveiled

10 June 2026
YY Group Holding shares surged to $0.165 on heavy volume after announcing a commercial humanoid-robotics initiative using Unitree G1 robots and facility-management data, reframing the company as a robotics-and-AI data play; the rally comes despite 2025 net loss, dilution risk from a relaunched at-the-market share-sale program, and no disclosed robot-related revenue or contracts.
Confluent stock edges higher as IBM deal vote nears after fresh merger filing
Previous Story

Confluent stock edges higher as IBM deal vote nears after fresh merger filing

Oracle stock rebounds after a bruising week — what traders are watching next for ORCL
Next Story

Oracle stock rebounds after a bruising week — what traders are watching next for ORCL

Go toTop